Hedge Fund - Logos Capital
Apellis Pharmaceuticals Inc. (APLS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $0 | 0% | 0 | $27.63 |
| 2 | 2024 - Q4 (2024-12-31) | $15,955,000 | 1.86% | 500,000 | $30.07 |
| 3 | 2024 - Q3 (2024-09-30) | $0 | 0% | 0 | $37.03 |
| 4 | 2024 - Q2 (2024-06-30) | $15,344,000 | 1.23% | 400,000 | $45.29 |
| 5 | 2024 - Q1 (2024-03-31) | $47,024,000 | 3.8% | 800,000 | $63.75 |
| 6 | 2023 - Q4 (2023-12-31) | $56,867,000 | 5.3% | 950,000 | $50.73 |
| 7 | 2023 - Q3 (2023-09-30) | $28,530,000 | 3.8% | 750,000 | $43.93 |
| 8 | 2023 - Q2 (2023-06-30) | $56,937,500 | 7.74% | 625,000 | $86.28 |
| 9 | 2023 - Q1 (2023-03-31) | $52,768,000 | 7.55% | 800,000 | $57.70 |
| 10 | 2022 - Q4 (2022-12-31) | $69,808,500 | 8.17% | 1,350,000 | $53.04 |
| 11 | 2022 - Q3 (2022-09-30) | $88,790,000 | 10.91% | 1,300,000 | $59.17 |
| 12 | 2022 - Q2 (2022-06-30) | $67,830,000 | 12.44% | 1,500,000 | $45.59 |
| 13 | 2022 - Q1 (2022-03-31) | $45,729,000 | 5.92% | 900,000 | $44.15 |
| 14 | 2021 - Q4 (2021-12-31) | $47,280,000 | 4.87% | 1,000,000 | $39.37 |
| 15 | 2021 - Q3 (2021-09-30) | $47,792,000 | 3.44% | 1,450,000 | $56.19 |
| 16 | 2021 - Q2 (2021-06-30) | $22,120,000 | 1.85% | 350,000 | $51.60 |
| 17 | 2021 - Q1 (2021-03-31) | $0 | 0% | 0 | $47.32 |
| 18 | 2020 - Q4 (2020-12-31) | $17,160,000 | 1.47% | 300,000 | $42.30 |
| 19 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $35.50 |
| 20 | 2019 - Q4 (2019-12-31) | $17,977,000 | 4.43% | 587,108 | $27.68 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center